 Cheryl Ackert-Bicknell
Concepts (366)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteoporosis | 15 | 2024 | 244 | 3.470 |
Why?
| | Bone Density | 30 | 2023 | 490 | 2.960 |
Why?
| | Bone and Bones | 14 | 2023 | 317 | 1.950 |
Why?
| | Quantitative Trait Loci | 19 | 2022 | 376 | 1.780 |
Why?
| | Genome-Wide Association Study | 20 | 2023 | 1398 | 1.680 |
Why?
| | Osteoblasts | 14 | 2021 | 131 | 1.110 |
Why?
| | Zebrafish | 5 | 2024 | 501 | 0.990 |
Why?
| | Genetic Variation | 8 | 2019 | 1003 | 0.850 |
Why?
| | Femur | 10 | 2018 | 256 | 0.820 |
Why?
| | Chromosome Mapping | 10 | 2019 | 515 | 0.790 |
Why?
| | Musculoskeletal Diseases | 2 | 2024 | 85 | 0.780 |
Why?
| | Intervertebral Disc | 1 | 2023 | 37 | 0.770 |
Why?
| | Mice | 55 | 2024 | 17848 | 0.770 |
Why?
| | Intervertebral Disc Degeneration | 1 | 2023 | 34 | 0.770 |
Why?
| | Intervertebral Disc Displacement | 1 | 2023 | 41 | 0.760 |
Why?
| | Animals | 66 | 2024 | 37309 | 0.650 |
Why?
| | Osteoporotic Fractures | 2 | 2022 | 61 | 0.630 |
Why?
| | Spine | 2 | 2018 | 179 | 0.610 |
Why?
| | Genome | 3 | 2019 | 299 | 0.600 |
Why?
| | Fractures, Bone | 4 | 2022 | 394 | 0.590 |
Why?
| | Insulin-Like Growth Factor I | 9 | 2008 | 324 | 0.590 |
Why?
| | Fracture Healing | 2 | 2016 | 83 | 0.580 |
Why?
| | Mice, Inbred C57BL | 16 | 2020 | 5812 | 0.510 |
Why?
| | Skeleton | 1 | 2016 | 6 | 0.510 |
Why?
| | Polymorphism, Single Nucleotide | 17 | 2021 | 2143 | 0.500 |
Why?
| | Alternative Splicing | 1 | 2018 | 227 | 0.500 |
Why?
| | PPAR gamma | 5 | 2010 | 180 | 0.490 |
Why?
| | Phenotype | 19 | 2024 | 3160 | 0.490 |
Why?
| | Laboratory Animal Science | 1 | 2015 | 4 | 0.470 |
Why?
| | Diphosphonates | 1 | 2016 | 69 | 0.470 |
Why?
| | Bone Density Conservation Agents | 1 | 2016 | 82 | 0.460 |
Why?
| | Gene-Environment Interaction | 2 | 2013 | 190 | 0.450 |
Why?
| | Lipoproteins, HDL | 2 | 2013 | 77 | 0.400 |
Why?
| | Disease Models, Animal | 8 | 2024 | 4333 | 0.400 |
Why?
| | Body Composition | 6 | 2010 | 696 | 0.390 |
Why?
| | GATA Transcription Factors | 1 | 2012 | 7 | 0.370 |
Why?
| | Aging | 5 | 2021 | 1859 | 0.370 |
Why?
| | Hip | 1 | 2012 | 56 | 0.360 |
Why?
| | Cholesterol, HDL | 1 | 2012 | 196 | 0.350 |
Why?
| | Mice, Inbred Strains | 9 | 2015 | 411 | 0.340 |
Why?
| | Mice, Inbred C3H | 9 | 2010 | 269 | 0.340 |
Why?
| | Genetic Predisposition to Disease | 7 | 2022 | 2368 | 0.340 |
Why?
| | Thiazolidinediones | 2 | 2008 | 139 | 0.340 |
Why?
| | Chromosome Inversion | 2 | 2007 | 18 | 0.330 |
Why?
| | DNA-Binding Proteins | 3 | 2020 | 1476 | 0.330 |
Why?
| | Dietary Fats | 2 | 2011 | 303 | 0.330 |
Why?
| | Transcription Factors | 4 | 2023 | 1707 | 0.330 |
Why?
| | Gene Regulatory Networks | 3 | 2021 | 310 | 0.320 |
Why?
| | Osteoarthritis | 2 | 2025 | 200 | 0.310 |
Why?
| | Crosses, Genetic | 6 | 2012 | 135 | 0.310 |
Why?
| | Carrier Proteins | 5 | 2017 | 739 | 0.290 |
Why?
| | Gene Expression Regulation | 9 | 2020 | 2602 | 0.280 |
Why?
| | Genetic Association Studies | 3 | 2016 | 373 | 0.260 |
Why?
| | Chromosomes, Mammalian | 4 | 2012 | 28 | 0.260 |
Why?
| | Osteogenesis | 4 | 2021 | 197 | 0.260 |
Why?
| | Humans | 39 | 2025 | 138651 | 0.250 |
Why?
| | Cell Differentiation | 6 | 2021 | 2000 | 0.250 |
Why?
| | CRISPR-Cas Systems | 2 | 2024 | 127 | 0.240 |
Why?
| | Mice, Knockout | 9 | 2020 | 3038 | 0.230 |
Why?
| | Genetic Pleiotropy | 2 | 2017 | 30 | 0.230 |
Why?
| | Pseudarthrosis | 1 | 2024 | 13 | 0.220 |
Why?
| | Diskectomy | 1 | 2024 | 25 | 0.220 |
Why?
| | Meta-Analysis as Topic | 2 | 2017 | 186 | 0.220 |
Why?
| | Synovial Membrane | 1 | 2025 | 121 | 0.220 |
Why?
| | Lipoproteins, LDL | 1 | 2024 | 115 | 0.220 |
Why?
| | Ankle Joint | 1 | 2025 | 115 | 0.210 |
Why?
| | Calcification, Physiologic | 2 | 2021 | 33 | 0.210 |
Why?
| | Bone Diseases | 2 | 2015 | 64 | 0.210 |
Why?
| | X-Ray Microtomography | 4 | 2018 | 97 | 0.210 |
Why?
| | Allelic Imbalance | 1 | 2023 | 9 | 0.210 |
Why?
| | Adipose Tissue | 2 | 2007 | 643 | 0.210 |
Why?
| | Sarcopenia | 2 | 2024 | 81 | 0.200 |
Why?
| | Cervical Vertebrae | 1 | 2024 | 140 | 0.200 |
Why?
| | Longevity | 2 | 2015 | 174 | 0.200 |
Why?
| | Organ Size | 4 | 2017 | 474 | 0.200 |
Why?
| | Craniosynostoses | 1 | 2023 | 57 | 0.190 |
Why?
| | Femoracetabular Impingement | 1 | 2022 | 35 | 0.190 |
Why?
| | Behavior, Animal | 2 | 2016 | 512 | 0.190 |
Why?
| | Osteoarthritis, Hip | 1 | 2022 | 47 | 0.190 |
Why?
| | Exons | 2 | 2018 | 355 | 0.190 |
Why?
| | Biology | 1 | 2023 | 90 | 0.180 |
Why?
| | HMGB1 Protein | 1 | 2022 | 51 | 0.180 |
Why?
| | Mammals | 1 | 2023 | 286 | 0.180 |
Why?
| | Skull | 3 | 2023 | 146 | 0.180 |
Why?
| | Cell Culture Techniques | 2 | 2022 | 364 | 0.180 |
Why?
| | Zebrafish Proteins | 1 | 2024 | 288 | 0.180 |
Why?
| | Regenerative Medicine | 1 | 2022 | 52 | 0.180 |
Why?
| | Transcriptome | 6 | 2025 | 970 | 0.180 |
Why?
| | Musculoskeletal System | 1 | 2022 | 49 | 0.180 |
Why?
| | Spinal Fusion | 1 | 2024 | 252 | 0.180 |
Why?
| | Genotype | 5 | 2018 | 1873 | 0.180 |
Why?
| | Erythropoietin | 1 | 2022 | 97 | 0.170 |
Why?
| | Bone Marrow | 2 | 2015 | 300 | 0.170 |
Why?
| | Anemia | 1 | 2022 | 175 | 0.170 |
Why?
| | Antibody-Producing Cells | 1 | 2020 | 30 | 0.170 |
Why?
| | Male | 28 | 2025 | 68216 | 0.160 |
Why?
| | Female | 35 | 2025 | 73913 | 0.160 |
Why?
| | Muscle Weakness | 1 | 2021 | 92 | 0.160 |
Why?
| | Adipogenesis | 2 | 2010 | 57 | 0.160 |
Why?
| | Cell Separation | 1 | 2021 | 317 | 0.160 |
Why?
| | Computational Biology | 2 | 2021 | 650 | 0.160 |
Why?
| | Antibodies, Bacterial | 1 | 2020 | 146 | 0.160 |
Why?
| | Tetraspanins | 1 | 2019 | 19 | 0.150 |
Why?
| | Cartilage, Articular | 1 | 2022 | 330 | 0.150 |
Why?
| | Promoter Regions, Genetic | 2 | 2018 | 1239 | 0.150 |
Why?
| | Untranslated Regions | 1 | 2018 | 3 | 0.150 |
Why?
| | Sex Characteristics | 2 | 2018 | 768 | 0.140 |
Why?
| | RAW 264.7 Cells | 1 | 2018 | 50 | 0.140 |
Why?
| | Information Management | 1 | 2018 | 17 | 0.140 |
Why?
| | Osteomyelitis | 1 | 2020 | 135 | 0.140 |
Why?
| | Musculoskeletal Development | 1 | 2017 | 2 | 0.140 |
Why?
| | Cell Line | 5 | 2018 | 2874 | 0.140 |
Why?
| | Sterol Regulatory Element Binding Protein 1 | 1 | 2017 | 58 | 0.130 |
Why?
| | Genetic Markers | 2 | 2016 | 345 | 0.130 |
Why?
| | Quantitative Trait, Heritable | 2 | 2018 | 123 | 0.130 |
Why?
| | Calcaneus | 1 | 2017 | 32 | 0.130 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-5 | 1 | 2017 | 8 | 0.130 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2019 | 206 | 0.130 |
Why?
| | Pelvic Bones | 1 | 2019 | 127 | 0.130 |
Why?
| | Nuclear Proteins | 3 | 2011 | 708 | 0.130 |
Why?
| | Species Specificity | 5 | 2014 | 582 | 0.130 |
Why?
| | Receptor, EphB2 | 1 | 2016 | 4 | 0.130 |
Why?
| | Excitatory Amino Acid Transporter 1 | 1 | 2016 | 6 | 0.130 |
Why?
| | Wnt Proteins | 2 | 2015 | 135 | 0.130 |
Why?
| | Leukocytes | 1 | 2018 | 309 | 0.130 |
Why?
| | Animals, Outbred Strains | 1 | 2016 | 5 | 0.130 |
Why?
| | Glycoproteins | 3 | 2003 | 359 | 0.130 |
Why?
| | Retinal Vessels | 1 | 2017 | 70 | 0.130 |
Why?
| | Histological Techniques | 1 | 2016 | 40 | 0.130 |
Why?
| | Minerals | 1 | 2016 | 43 | 0.130 |
Why?
| | Mutagenesis | 1 | 2017 | 183 | 0.120 |
Why?
| | Staphylococcus aureus | 1 | 2020 | 433 | 0.120 |
Why?
| | Databases, Genetic | 2 | 2014 | 241 | 0.120 |
Why?
| | Sepsis | 1 | 2022 | 606 | 0.120 |
Why?
| | Spinal Fractures | 1 | 2016 | 74 | 0.120 |
Why?
| | Program Development | 1 | 2018 | 362 | 0.120 |
Why?
| | Immunoglobulin G | 1 | 2020 | 903 | 0.120 |
Why?
| | Staphylococcal Infections | 1 | 2020 | 386 | 0.120 |
Why?
| | Rodent Diseases | 1 | 2015 | 28 | 0.120 |
Why?
| | Animal Structures | 1 | 2015 | 9 | 0.120 |
Why?
| | Stem Cells | 2 | 2022 | 598 | 0.120 |
Why?
| | Bone Resorption | 1 | 2016 | 85 | 0.120 |
Why?
| | Haplotypes | 3 | 2012 | 494 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2021 | 875 | 0.110 |
Why?
| | Fracture Fixation, Intramedullary | 1 | 2015 | 55 | 0.110 |
Why?
| | Gene Expression Profiling | 4 | 2017 | 1755 | 0.110 |
Why?
| | Linkage Disequilibrium | 3 | 2021 | 260 | 0.110 |
Why?
| | Rats | 1 | 2023 | 5594 | 0.110 |
Why?
| | Face | 1 | 2015 | 173 | 0.110 |
Why?
| | Guanine Nucleotide Exchange Factors | 1 | 2014 | 65 | 0.110 |
Why?
| | Urination | 1 | 2014 | 45 | 0.110 |
Why?
| | Mice, Transgenic | 3 | 2015 | 2177 | 0.100 |
Why?
| | Urodynamics | 1 | 2014 | 46 | 0.100 |
Why?
| | Transcription, Genetic | 4 | 2020 | 1462 | 0.100 |
Why?
| | Inbreeding | 2 | 2011 | 19 | 0.100 |
Why?
| | Animals, Newborn | 4 | 2021 | 858 | 0.100 |
Why?
| | Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 2013 | 14 | 0.100 |
Why?
| | Genome, Human | 1 | 2015 | 418 | 0.100 |
Why?
| | Lower Urinary Tract Symptoms | 1 | 2014 | 61 | 0.100 |
Why?
| | Actins | 2 | 2024 | 420 | 0.100 |
Why?
| | Genomics | 3 | 2015 | 804 | 0.100 |
Why?
| | Ovariectomy | 2 | 2011 | 155 | 0.100 |
Why?
| | Postoperative Complications | 1 | 2024 | 2701 | 0.100 |
Why?
| | Adipocytes | 3 | 2010 | 227 | 0.090 |
Why?
| | Cohort Studies | 4 | 2024 | 5729 | 0.090 |
Why?
| | Databases, Factual | 1 | 2018 | 1399 | 0.090 |
Why?
| | Sequence Analysis, DNA | 3 | 2015 | 827 | 0.090 |
Why?
| | Bone Marrow Cells | 4 | 2010 | 325 | 0.090 |
Why?
| | Lod Score | 1 | 2012 | 65 | 0.090 |
Why?
| | RNA Editing | 1 | 2012 | 24 | 0.090 |
Why?
| | Stromal Cells | 4 | 2006 | 111 | 0.090 |
Why?
| | Adipose Tissue, White | 1 | 2012 | 43 | 0.090 |
Why?
| | Liver | 6 | 2012 | 1876 | 0.090 |
Why?
| | Homeodomain Proteins | 1 | 2015 | 510 | 0.090 |
Why?
| | Environment | 1 | 2013 | 339 | 0.090 |
Why?
| | 3' Untranslated Regions | 1 | 2012 | 145 | 0.090 |
Why?
| | Receptors, Cytoplasmic and Nuclear | 2 | 2003 | 206 | 0.090 |
Why?
| | Inflammation | 2 | 2022 | 2857 | 0.090 |
Why?
| | Myogenic Regulatory Factors | 1 | 2010 | 55 | 0.080 |
Why?
| | MEF2 Transcription Factors | 1 | 2010 | 59 | 0.080 |
Why?
| | Membrane Glycoproteins | 2 | 2003 | 500 | 0.080 |
Why?
| | Gastrointestinal Microbiome | 1 | 2018 | 700 | 0.080 |
Why?
| | Reproducibility of Results | 3 | 2019 | 3311 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2018 | 2861 | 0.080 |
Why?
| | Sequence Analysis, RNA | 2 | 2022 | 452 | 0.080 |
Why?
| | Estrogens | 1 | 2012 | 369 | 0.070 |
Why?
| | Bone Development | 2 | 2014 | 54 | 0.070 |
Why?
| | Circadian Rhythm | 2 | 2010 | 490 | 0.070 |
Why?
| | Research Design | 1 | 2015 | 1120 | 0.070 |
Why?
| | Mice, Inbred DBA | 1 | 2008 | 199 | 0.070 |
Why?
| | Repressor Proteins | 1 | 2012 | 423 | 0.070 |
Why?
| | Aged | 6 | 2025 | 24182 | 0.070 |
Why?
| | Gene Expression | 4 | 2019 | 1494 | 0.070 |
Why?
| | RNA, Messenger | 7 | 2019 | 2817 | 0.070 |
Why?
| | Alleles | 2 | 2008 | 887 | 0.070 |
Why?
| | Europe | 2 | 2021 | 405 | 0.070 |
Why?
| | Models, Animal | 2 | 2014 | 399 | 0.070 |
Why?
| | Somatomedins | 1 | 2006 | 28 | 0.070 |
Why?
| | Molecular Sequence Annotation | 2 | 2017 | 99 | 0.060 |
Why?
| | Cells, Cultured | 4 | 2020 | 4175 | 0.060 |
Why?
| | Muscle, Skeletal | 3 | 2024 | 1740 | 0.060 |
Why?
| | Mutation | 1 | 2017 | 3998 | 0.060 |
Why?
| | Bone Remodeling | 1 | 2006 | 77 | 0.060 |
Why?
| | MicroRNAs | 1 | 2012 | 680 | 0.060 |
Why?
| | Keratins | 1 | 2006 | 171 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2025 | 3581 | 0.060 |
Why?
| | Myogenic Regulatory Factor 5 | 1 | 2024 | 7 | 0.060 |
Why?
| | Mammary Glands, Animal | 1 | 2006 | 130 | 0.060 |
Why?
| | Morphogenesis | 1 | 2006 | 170 | 0.060 |
Why?
| | MyoD Protein | 1 | 2024 | 35 | 0.060 |
Why?
| | Fish Oils | 1 | 2024 | 26 | 0.060 |
Why?
| | Obesity | 1 | 2018 | 2994 | 0.060 |
Why?
| | Gene Knockout Techniques | 1 | 2024 | 118 | 0.050 |
Why?
| | Granulosa Cell Tumor | 1 | 2003 | 6 | 0.050 |
Why?
| | Muscular Diseases | 1 | 2024 | 113 | 0.050 |
Why?
| | Muscle Development | 1 | 2024 | 115 | 0.050 |
Why?
| | X Chromosome | 1 | 2003 | 54 | 0.050 |
Why?
| | Genetic Diseases, X-Linked | 1 | 2003 | 24 | 0.050 |
Why?
| | Larva | 1 | 2024 | 235 | 0.050 |
Why?
| | Adiposity | 1 | 2008 | 522 | 0.050 |
Why?
| | Middle Aged | 5 | 2025 | 33792 | 0.050 |
Why?
| | Transcription Initiation Site | 1 | 2023 | 43 | 0.050 |
Why?
| | Oncogenes | 1 | 2003 | 118 | 0.050 |
Why?
| | Uncertainty | 1 | 2023 | 130 | 0.050 |
Why?
| | Lipids | 1 | 2007 | 674 | 0.050 |
Why?
| | Polymorphism, Genetic | 1 | 2005 | 636 | 0.050 |
Why?
| | Osteoclasts | 2 | 2017 | 51 | 0.050 |
Why?
| | Receptors, Erythropoietin | 1 | 2022 | 20 | 0.050 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 981 | 0.050 |
Why?
| | Erythropoiesis | 1 | 2022 | 56 | 0.050 |
Why?
| | Protein Isoforms | 1 | 2023 | 396 | 0.050 |
Why?
| | Body Weight | 3 | 2017 | 990 | 0.050 |
Why?
| | Adaptor Proteins, Signal Transducing | 1 | 2024 | 430 | 0.040 |
Why?
| | Gene Ontology | 1 | 2021 | 54 | 0.040 |
Why?
| | Growth Differentiation Factor 5 | 1 | 2021 | 3 | 0.040 |
Why?
| | Bone Matrix | 1 | 2021 | 6 | 0.040 |
Why?
| | HLA-DQ alpha-Chains | 1 | 2021 | 16 | 0.040 |
Why?
| | Lipid Metabolism | 1 | 2024 | 523 | 0.040 |
Why?
| | Adult | 5 | 2025 | 38296 | 0.040 |
Why?
| | Hip Joint | 1 | 2022 | 169 | 0.040 |
Why?
| | Clinical Protocols | 1 | 2022 | 272 | 0.040 |
Why?
| | Gene Frequency | 2 | 2015 | 504 | 0.040 |
Why?
| | Wnt4 Protein | 1 | 2020 | 18 | 0.040 |
Why?
| | Growth Hormone | 3 | 2006 | 102 | 0.040 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 447 | 0.040 |
Why?
| | Hypoglycemic Agents | 1 | 2008 | 1302 | 0.040 |
Why?
| | Cortical Bone | 1 | 2019 | 19 | 0.040 |
Why?
| | Calcium | 1 | 2024 | 1185 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2003 | 894 | 0.040 |
Why?
| | Bifidobacterium longum | 1 | 2018 | 6 | 0.040 |
Why?
| | ROC Curve | 1 | 2020 | 566 | 0.040 |
Why?
| | Prospective Studies | 2 | 2025 | 7639 | 0.040 |
Why?
| | Hip Fractures | 1 | 2019 | 86 | 0.030 |
Why?
| | Muscle Strength | 1 | 2021 | 317 | 0.030 |
Why?
| | Oligosaccharides | 1 | 2018 | 59 | 0.030 |
Why?
| | Glypicans | 1 | 2017 | 11 | 0.030 |
Why?
| | Tissue Engineering | 1 | 2022 | 425 | 0.030 |
Why?
| | Ovarian Neoplasms | 1 | 2003 | 575 | 0.030 |
Why?
| | Osteochondrodysplasias | 1 | 2017 | 20 | 0.030 |
Why?
| | Osteocytes | 1 | 2017 | 30 | 0.030 |
Why?
| | Electroretinography | 1 | 2017 | 50 | 0.030 |
Why?
| | Growth Disorders | 1 | 2017 | 85 | 0.030 |
Why?
| | Homozygote | 1 | 2017 | 203 | 0.030 |
Why?
| | Cancellous Bone | 1 | 2016 | 26 | 0.030 |
Why?
| | Dysbiosis | 1 | 2018 | 182 | 0.030 |
Why?
| | Genetic Loci | 1 | 2018 | 283 | 0.030 |
Why?
| | RNA | 1 | 2022 | 928 | 0.030 |
Why?
| | Mice, Congenic | 2 | 2006 | 23 | 0.030 |
Why?
| | Polymerase Chain Reaction | 2 | 2012 | 1049 | 0.030 |
Why?
| | Cryopreservation | 1 | 2016 | 104 | 0.030 |
Why?
| | Age Factors | 2 | 2018 | 3274 | 0.030 |
Why?
| | Oligonucleotide Array Sequence Analysis | 2 | 2010 | 760 | 0.030 |
Why?
| | Base Sequence | 2 | 2012 | 2182 | 0.030 |
Why?
| | Regression Analysis | 1 | 2018 | 1015 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2015 | 309 | 0.030 |
Why?
| | Mice, Inbred NZB | 2 | 2006 | 16 | 0.030 |
Why?
| | Wnt Signaling Pathway | 1 | 2017 | 196 | 0.030 |
Why?
| | Disease Progression | 1 | 2022 | 2734 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2020 | 2039 | 0.030 |
Why?
| | Tibial Fractures | 1 | 2015 | 68 | 0.030 |
Why?
| | Molecular Sequence Data | 2 | 2012 | 2928 | 0.030 |
Why?
| | Genes, Reporter | 1 | 2015 | 273 | 0.030 |
Why?
| | Lumbar Vertebrae | 1 | 2016 | 248 | 0.030 |
Why?
| | Exome | 1 | 2015 | 235 | 0.030 |
Why?
| | Epigenesis, Genetic | 1 | 2019 | 647 | 0.030 |
Why?
| | Insulin-Like Growth Factor Binding Proteins | 2 | 2004 | 25 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2017 | 1497 | 0.030 |
Why?
| | Receptor Activator of Nuclear Factor-kappa B | 2 | 2003 | 9 | 0.030 |
Why?
| | Osteoprotegerin | 2 | 2003 | 24 | 0.030 |
Why?
| | RANK Ligand | 2 | 2003 | 29 | 0.030 |
Why?
| | Upper Extremity | 1 | 2014 | 105 | 0.020 |
Why?
| | Fibrosis | 1 | 2015 | 542 | 0.020 |
Why?
| | Biopsy | 1 | 2016 | 1093 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor | 2 | 2003 | 166 | 0.020 |
Why?
| | Child | 3 | 2018 | 21883 | 0.020 |
Why?
| | Polymorphism, Restriction Fragment Length | 1 | 2012 | 68 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 349 | 0.020 |
Why?
| | Absorptiometry, Photon | 1 | 2013 | 263 | 0.020 |
Why?
| | Models, Biological | 2 | 2010 | 1815 | 0.020 |
Why?
| | Litter Size | 1 | 2011 | 18 | 0.020 |
Why?
| | Software | 1 | 2016 | 667 | 0.020 |
Why?
| | Tissue Inhibitor of Metalloproteinase-2 | 1 | 2010 | 15 | 0.020 |
Why?
| | Biomechanical Phenomena | 2 | 2004 | 816 | 0.020 |
Why?
| | Macrophages | 1 | 2018 | 1545 | 0.020 |
Why?
| | 3T3-L1 Cells | 1 | 2010 | 37 | 0.020 |
Why?
| | Mice, Inbred BALB C | 1 | 2013 | 1261 | 0.020 |
Why?
| | ATP-Binding Cassette Transporters | 1 | 2010 | 121 | 0.020 |
Why?
| | Lower Extremity | 1 | 2014 | 438 | 0.020 |
Why?
| | Active Transport, Cell Nucleus | 1 | 2010 | 122 | 0.020 |
Why?
| | Lipoproteins | 1 | 2010 | 160 | 0.020 |
Why?
| | Sex Factors | 1 | 2015 | 2058 | 0.020 |
Why?
| | Risk Factors | 2 | 2016 | 10398 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2010 | 515 | 0.020 |
Why?
| | Meiosis | 1 | 2009 | 84 | 0.020 |
Why?
| | Biomarkers | 1 | 2020 | 4111 | 0.020 |
Why?
| | Chromosomes | 1 | 2009 | 106 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2021 | 7683 | 0.020 |
Why?
| | Bayes Theorem | 1 | 2010 | 412 | 0.020 |
Why?
| | Cell Lineage | 1 | 2010 | 352 | 0.020 |
Why?
| | Dissection | 1 | 2007 | 54 | 0.020 |
Why?
| | Insulin-Like Growth Factor Binding Protein 4 | 1 | 2006 | 4 | 0.020 |
Why?
| | Insulin-Like Growth Factor Binding Protein 2 | 1 | 2006 | 8 | 0.020 |
Why?
| | Insulin-Like Growth Factor II | 1 | 2006 | 22 | 0.020 |
Why?
| | Artificial Intelligence | 1 | 2010 | 294 | 0.020 |
Why?
| | Insulin-Like Growth Factor Binding Protein 3 | 1 | 2006 | 36 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 2838 | 0.020 |
Why?
| | Receptor, IGF Type 1 | 1 | 2006 | 64 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 15860 | 0.020 |
Why?
| | Microarray Analysis | 1 | 2006 | 117 | 0.020 |
Why?
| | Genetic Linkage | 1 | 2007 | 292 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2018 | 6143 | 0.020 |
Why?
| | Receptors, Somatotropin | 1 | 2005 | 10 | 0.010 |
Why?
| | Cholesterol | 1 | 2007 | 401 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2005 | 361 | 0.010 |
Why?
| | Triglycerides | 1 | 2007 | 515 | 0.010 |
Why?
| | DNA Primers | 1 | 2006 | 509 | 0.010 |
Why?
| | Drug Administration Schedule | 1 | 2006 | 769 | 0.010 |
Why?
| | Transfection | 1 | 2006 | 942 | 0.010 |
Why?
| | Down-Regulation | 1 | 2006 | 638 | 0.010 |
Why?
| | Stress, Mechanical | 1 | 2006 | 487 | 0.010 |
Why?
| | Brain | 1 | 2016 | 2782 | 0.010 |
Why?
| | Alkaline Phosphatase | 1 | 2004 | 151 | 0.010 |
Why?
| | Radiography | 1 | 2006 | 846 | 0.010 |
Why?
| | Nitric Oxide Donors | 1 | 2003 | 21 | 0.010 |
Why?
| | Guanylate Cyclase | 1 | 2003 | 37 | 0.010 |
Why?
| | Nitroprusside | 1 | 2003 | 71 | 0.010 |
Why?
| | Infant | 1 | 2018 | 9565 | 0.010 |
Why?
| | Cyclic GMP | 1 | 2003 | 91 | 0.010 |
Why?
| | Calcitriol | 1 | 2003 | 59 | 0.010 |
Why?
| | Blotting, Western | 1 | 2006 | 1229 | 0.010 |
Why?
| | Parathyroid Hormone | 1 | 2003 | 111 | 0.010 |
Why?
| | Algorithms | 1 | 2010 | 1718 | 0.010 |
Why?
| | Child, Preschool | 1 | 2018 | 11130 | 0.010 |
Why?
| | Recombination, Genetic | 1 | 2003 | 207 | 0.010 |
Why?
| | Human Growth Hormone | 1 | 2002 | 48 | 0.010 |
Why?
| | Phylogeny | 1 | 2006 | 1007 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2006 | 1732 | 0.010 |
Why?
| | Pregnancy | 1 | 2014 | 6836 | 0.010 |
Why?
| | Tibia | 1 | 2002 | 180 | 0.010 |
Why?
| | Enzyme Inhibitors | 1 | 2003 | 850 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2002 | 1358 | 0.010 |
Why?
| | Kinetics | 1 | 2002 | 1654 | 0.010 |
Why?
| | NF-kappa B | 1 | 2002 | 679 | 0.010 |
Why?
| | Adolescent | 1 | 2018 | 21528 | 0.010 |
Why?
| | Young Adult | 1 | 2014 | 13322 | 0.010 |
Why?
| | Signal Transduction | 1 | 2006 | 5091 | 0.010 |
Why?
|
|
Ackert-Bicknell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|